Early stage biotech developing therapies for stress-related neuropsychiatric and mood disorders.
Industry: Health Care
First Day Return: -46.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/11/2021 |
Offer Price | $4.15 |
Price Range $4.13 - $4.17 | |
Offer Shares (mm) | 3.2 |
Deal Size ($mm) | $13 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/26/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $13 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2004 |
Employees at IPO | 2 |
Website www.protagenic.com |